Dean is a Class of 2022 undergraduate at the Peking University School of Pharmaceutical Sciences. He is interested in nucleic acid biology and AI4S, particularly in emerging nucleic acid therapeutics (stRNA and saRNA), and has a strong passion for the cutting-edge field of AIVC in systems biology. Guomics constructs its AIVC using data derived from advanced mass spectrometry proteomics technology, giving it unique advantages over transcriptomics-based Virtual Cell. He aspires to study cutting-edge mass spectrometry proteomics techniques at the intersection of these two frontier fields within Guomics, gain insights into the advantages of AI in constructing Virtual Cells, and draw inspiration for his future work in drug discovery and development.